The purpose of the study is to evaluate the physiological response to application of the Intrathoracic Pressure Regulator (ITPR) in patients with compromised cerebral circulation. The study will evaluate the physiological response to intrathoracic pressure regulation (IPR) therapy in hemodynamically stable patients with compromised cerebral circulation who are on ventilatory support.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
3
Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath. The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Cerebral Perfusion Pressure (CPP)
Change from baseline CPP compared with the CPP during use of the ITPR.
Time frame: During 240 minutes of device use
Mean Arterial Pressure (MAP)
Change from baseline MAP compared with the MAP during use of the ITPR.
Time frame: baseline to end of ITPR use
Intracranial Pressure (ICP)
Change from baseline ICP compared with the ICP during use of the ITPR.
Time frame: baseline to end of ITPR use
End-tidal Carbon Dioxide (EtCO2)
Change from baseline EtCO2 compared with the EtCO2 during use of the ITPR.
Time frame: baseline to end of ITPR use
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.